Saturday, April 4, 2020

Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications for P30 Alzheimer's Disease Research Centers (ADRCs). NIA-designated ADRCs serve as major sources of discovery into the nature of Alzheimer’s disease and Alzheimer's disease-related dementias (AD/ADRD) and into the development of more effective approaches to prevention, diagnosis, care, and therapy. They contribute significantly to the development of shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with other NIH-funded programs and investigators.